ADHD: Symptoms, Brain Science, Medication & Treatment

Halfway through a meeting, your mind has already drifted to next weekend's plans. Four tasks sit open on your desk, each half-finished. The moment a phone notification pops up, the report you were writing evaporates from your working memory. It is not that you are not trying. It feels like your brain simply lacks a "lock on" button.

If this pattern has followed you since childhood and is now affecting your work, education, or relationships, there is a name for it: attention-deficit/hyperactivity disorder (ADHD). Global prevalence in children is estimated at 5% to 7%, while in adults it sits around 2.5% to 5%^[1]. The outdated notion that ADHD is a childhood condition that disappears with age has been firmly debunked. Roughly two-thirds of children with ADHD continue to meet diagnostic criteria or experience significant functional impairment into adulthood.

This article approaches ADHD from the neuroscience outward: why it is not about laziness or willpower, how the diagnosis is made, which treatments have the strongest evidence, and where adults can begin with self-screening.

What Is ADHD?

ADHD is classified as a neurodevelopmental disorder, meaning its origins lie in differences in how the brain develops, not in parenting style or character flaws. The DSM-5 divides ADHD symptoms into two core dimensions^[2]:

Inattention. Difficulty sustaining focus, being easily distracted by external stimuli, frequently forgetting daily tasks, poor organization, and avoidance of tasks that require sustained mental effort.

Hyperactivity and impulsivity. Restlessness, fidgeting, excessive talking, difficulty waiting one's turn, and interrupting others. In adults, the overt "can't sit still" presentation often transforms into an internal sense of restlessness, difficulty relaxing, and impulsive decision-making.

Depending on the symptom profile, ADHD is further specified as predominantly inattentive, predominantly hyperactive-impulsive, or combined presentation. Among adults, the inattentive presentation tends to be more common, because visible hyperactivity typically diminishes with age while attentional difficulties persist.

One important diagnostic requirement: symptoms must have been present before age 12. This does not mean you needed a childhood diagnosis. It means that, looking back, the difficulties can be traced to that period of your life.

What Happens in the Brain

The brains of individuals with ADHD differ from neurotypical brains in measurable structural and functional ways. The World Federation of ADHD International Consensus Statement compiled 208 evidence-based conclusions about the disorder^[1], including the following neuroscience findings:

Prefrontal cortex hypofunction. The prefrontal cortex is the brain's executive manager, responsible for planning, organization, impulse inhibition, and delayed gratification. In ADHD, prefrontal activation is lower than expected, which means these executive functions operate less efficiently. This is why someone with ADHD may know exactly what they should do yet struggle enormously to actually do it.

Dopamine system dysregulation. Dopamine is the brain's reward and motivation signal. Prefrontal dopamine transmission is reduced in ADHD, leaving the brain without enough drive for tasks that are important but not inherently stimulating. Conversely, the dopamine system may respond disproportionately to novelty, which explains why a person with ADHD can hyperfocus on something engaging for hours while being unable to spend ten minutes on a routine assignment.

Norepinephrine involvement. Norepinephrine plays a key role in sustaining attention and regulating alertness. In ADHD, norepinephrine signaling is suboptimal, causing the attention "spotlight" to wander and making it difficult to maintain a steady lock on a target.

Structural brain differences. Neuroimaging studies show that individuals with ADHD have slightly smaller basal ganglia and cerebellum volumes, and that prefrontal cortical maturation is delayed by approximately two to three years compared to age-matched peers^[1]. These differences reflect a variation in developmental timing, not brain damage.

What ADHD Looks Like

Textbook symptom lists are one thing; the lived experience that patients describe in my clinic is another. Here is a snapshot across age groups:

Typical ADHD presentations by age

Adult ADHD is particularly easy to overlook because many individuals have developed elaborate compensatory strategies over the years: sticky notes everywhere, multiple alarms, detailed checklists. On the surface they appear to be managing. But maintaining those strategies is exhausting in itself. Patients frequently describe a feeling of "spending three times the effort to achieve what others do effortlessly."

Treatment

The goal of ADHD treatment is not to "cure" the condition but to help the brain operate more efficiently, reducing the impact of symptoms on daily life. International guidelines generally recommend a combination of medication and behavioral strategies as the most effective approach^[3].

Medication

Stimulant medications are recognized by every major guideline as the first-line pharmacological treatment for ADHD^[4]. The word "stimulant" can sound alarming, but the mechanism is straightforward: these medications enhance dopamine and norepinephrine transmission in the prefrontal cortex, enabling the "lock on" function to work as it should.

Medications commonly used for ADHD in Taiwan

A landmark 2018 network meta-analysis of 133 randomized controlled trials^[4] identified methylphenidate as the best first-choice medication for children and adolescents, while amphetamines showed the most robust efficacy data in adults. In Taiwan, methylphenidate and atomoxetine remain the main medication options used in routine clinical practice.

The most common concern I hear is, "Will I become addicted?" At therapeutic doses prescribed by a physician, methylphenidate and other stimulants do not produce addiction. Research actually shows that individuals with ADHD who receive appropriate pharmacological treatment have a lower risk of subsequent substance use disorders compared to those left untreated^[1].

Behavioral and Psychological Treatment

Medication adjusts the brain's "hardware" performance, but years of coping habits still need a "software update." That is where behavioral and psychological interventions come in.

Children: Behavioral Parent Training. For preschool and school-age children, international guidelines list behavioral parent training as the first-line nonpharmacological intervention^[3]. The focus is not on teaching the child to "behave," but on equipping parents with consistent reinforcement structures, effective instruction delivery, and positive reinforcement strategies to replace repetitive scolding.

Children: Organizational Skills Training. This teaches children how to manage their belongings, sequence homework tasks, and use checklists. Skills that seem straightforward need to be broken down into very concrete, practiced steps for a child with ADHD.

Adults: CBT Adapted for ADHD. Adult-focused CBT for ADHD targets time management, task initiation, organizational planning, and the frustration and low self-esteem that often accumulate from years of unrecognized ADHD. The European Consensus Statement on adult ADHD^[5] notes that combining CBT with medication produces further functional improvement, particularly in domains where medication alone falls short, such as organization and emotional regulation.

Repetitive Transcranial Magnetic Stimulation (rTMS)

Research on rTMS for ADHD remains at an early stage. A handful of small trials have explored stimulation of the dorsolateral prefrontal cortex (DLPFC) to improve attentional performance, with preliminary results suggesting possible benefit. However, sample sizes are too small and large-scale replication studies are lacking. No international guideline currently recommends rTMS as a standard ADHD treatment. If you are interested, it is best discussed thoroughly with your treating psychiatrist.

Self-Screening: The ASRS

If you are an adult who suspects you may have ADHD, a good starting point is the Adult ADHD Self-Report Scale (ASRS)^[6], developed by the World Health Organization. It comes in an 18-item full version and a 6-item screener. The 6-item screener has been validated with good sensitivity and can quickly indicate whether a full clinical evaluation is warranted.

You can also use the ASRS adult ADHD self-screening tool on this website. It is not a diagnosis, but it can help organize your concerns before a consultation.

Take the ASRS Adult ADHD Self-Screening Tool

If your result is positive, the next step is to schedule a psychiatric consultation for a comprehensive clinical assessment, which includes a detailed developmental history, symptom review, functional evaluation, and ruling out alternative diagnoses.

For children, the SNAP-IV is commonly used in clinical settings. It is completed by both parents and teachers, and scored by the clinician during the evaluation. It is not a self-administered tool.

When to Seek Help

Any of the following situations warrants scheduling an appointment with a psychiatrist:

• Attention difficulties have been present since childhood and continue to cause significant problems at work, school, or in relationships
• You have tried various self-management strategies (lists, alarms, apps) with limited success
• You frequently make costly mistakes due to distraction or impulsivity (losing important items, impulsive spending, chronic lateness affecting job performance)
• You have begun experiencing anxiety or depression, and you suspect these may stem from years of unaddressed ADHD
• Your child's school has raised persistent concerns about attention or behavior

ADHD diagnosis in adults is frequently delayed. Many people are not correctly identified until their thirties or forties. If you have long struggled with the feeling of "I know I am capable, but I just cannot perform consistently," that struggle deserves a proper evaluation.

References

1. Faraone SV, Banaschewski T, Coghill D, et al. The World Federation of ADHD International Consensus Statement: 208 evidence-based conclusions about the disorder. Neurosci Biobehav Rev. 2021;128:789-818. DOI · PubMed
2. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR). 2022.
3. National Institute for Health and Care Excellence (NICE). Attention deficit hyperactivity disorder: diagnosis and management (NG87). Updated 2024. NICE
4. Cortese S, Adamo N, Del Giovane C, et al. Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis. Lancet Psychiatry. 2018;5(9):727-738. DOI · PubMed
5. Kooij JJS, Bijlenga D, Salerno L, et al. Updated European Consensus Statement on diagnosis and treatment of adult ADHD. Eur Psychiatry. 2019;56:14-34. DOI · PubMed
6. Kessler RC, Adler L, Ames M, et al. The World Health Organization Adult ADHD Self-Report Scale (ASRS): a short screening scale for use in the general population. Psychol Med. 2005;35(2):245-256. DOI · PubMed